UNSPSC 51422327: Betamethasone dipropionate
Commodity
Code facts
- Part of
-
-
51000000
-
51420000
- 51422300
-
51420000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51422327
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a therapeutic glucocorticoid with the molecular formula C28H37FO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 826Y60901U, chemically known as 16-beta-methyl-1,4-pregnadiene-9-alpha-fluoro-11-beta,17-alpha,21-triol-3,20-dione but more generally known as betamethasone dipropionate, which bears US NIH Compound Identifier 9782.
Read the full definition
The base compound, Betamethasone, comes in many other forms, including base, acetate, acetate phosphate, acibutate, alcohol, benzoate, butyrate propionate, dihydrogen phosphate, disodium phosphate, phosphate, sodium, sodium phosphate, valerate, 17, 21-dipropionate, 17-acetate, 17 alpha-monopropionate, 17-benzoate, 17-dipropionate, 17-propionate, 17-propionate 21-methoxide, 17-valerate, 21-acetate, 21-disodium phosphate, 21-pentanoate, 21-phosphate, 21-phosphate disodium, and 21-valerate.
European Medicines Agency schedules Betamethasone dipropionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00783MIG. Most nations, for tariff and trade purposes, schedule betamethasone dipropionate under HS 29372200 and SITC 54153. As of Q4 2014, BETAMETHASONE DIPROPIONATE remains US FDA's Preferred Term for this commodity. Betamethasone dipropionate bears US NLM identifiers UMLS ID C0053523 and NCI Concept Code C47963. SMILES: CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CC.
About UNSPSC 51422327
UNSPSC 51422327 Betamethasone dipropionate is a Commodity code identifying a specific pharmaceutical product, yet the recent state and local procurement activity tagged under it reflects a significant mismatch: the sole recent opportunity solicits naloxone and drug deactivation systems rather than the corticosteroid named in the code. This mismatch suggests either a cataloging error in how the opportunity was tagged or that the code's actual procurement activity does not align with its nominal pharmaceutical scope. State and local buying under this code designation appears minimal or misattributed.
Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with a response deadline of July 26, 2023. The solicitation requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor pricing. Bidders must meet E-Verify compliance, drug-free workplace certification, and standard insurance requirements including workers' compensation and commercial general liability. The contract includes a two-year initial term with a one-year renewal option and carries a three-month probationary period. Because the opportunity's actual scope diverges materially from the code's named pharmaceutical, firms evaluating this code should confirm whether recent state and local demand for betamethasone dipropionate itself exists elsewhere or whether the code has been mislabeled in active procurement systems.
Quick answers
What is UNSPSC 51422327?
UNSPSC 51422327 is Betamethasone dipropionate, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51422327?
UNSPSC 51422327 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51422327
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code